Titus Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $555K | Hold |
4,720
| – | – | 0.28% | 60 |
|
|
2022
Q1 | $615K | Buy |
4,720
+45
| +1% | +$5.86K | 0.28% | 61 |
|
|
2021
Q4 | $713K | Buy |
4,675
+88
| +2% | +$13.4K | 0.32% | 53 |
|
|
2021
Q3 | $744K | Buy |
4,587
+54
| +1% | +$8.76K | 0.39% | 43 |
|
|
2021
Q2 | $742K | Buy |
4,533
+91
| +2% | +$14.9K | 0.4% | 41 |
|
|
2021
Q1 | $669K | Buy |
4,442
+373
| +9% | +$56.2K | 0.39% | 45 |
|
|
2020
Q4 | $616K | Buy |
4,069
+359
| +10% | +$54.3K | 0.38% | 49 |
|
|
2020
Q3 | $502K | Buy |
3,710
+62
| +2% | +$8.39K | 0.36% | 54 |
|
|
2020
Q2 | $499K | Buy |
3,648
+73
| +2% | +$9.99K | 0.39% | 50 |
|
|
2020
Q1 | $385K | Sell |
3,575
-69
| -2% | -$7.43K | 0.36% | 53 |
|
|
2019
Q4 | $439K | Sell |
3,644
-958
| -21% | -$115K | 0.44% | 52 |
|
|
2019
Q3 | $458K | Sell |
4,602
-159
| -3% | -$15.8K | 0.42% | 48 |
|
|
2019
Q2 | $519K | Sell |
4,761
-238
| -5% | -$25.9K | 0.51% | 39 |
|
|
2019
Q1 | $559 | Sell |
4,999
-306
| -6% | -$34 | 0.49% | 40 |
|
|
2018
Q4 | $511 | Sell |
5,305
-1,403
| -21% | -$135 | 0.44% | 36 |
|
|
2018
Q3 | $8.18M | Buy |
6,708
+569
| +9% | +$694K | 7.05% | 3 |
|
|
2018
Q2 | $674K | Sell |
6,139
-138
| -2% | -$15.2K | 0.72% | 26 |
|
|
2018
Q1 | $670K | Buy |
6,277
+1,237
| +25% | +$132K | 0.64% | 28 |
|
|
2017
Q4 | $542K | Buy |
+5,040
| New | +$542K | 0.61% | 30 |
|